GenVec Reports Positive Interim Survival Data For TNFerade In Pancreatic Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Results presented at American Society of Clinical Oncology annual meeting show significant advantage in median survival versus standard care alone.